Walbaum–Titran–Durieux–Crepin syndrome

Walbaum–Titran–Durieux–Crepin Syndrome

Walbaum–Titran–Durieux–Crepin syndrome is a rare genetic disorder characterized by a combination of ocular, skeletal, and neurological abnormalities. It is named after the researchers who first described the condition.

Clinical Features

Patients with Walbaum–Titran–Durieux–Crepin syndrome typically present with a range of symptoms that may include:

• Ocular abnormalities: These may include cataracts, glaucoma, and retinal detachment. Visual impairment is common and can vary in severity.
• Skeletal abnormalities: Affected individuals may exhibit dysplasia of the long bones, scoliosis, and joint hypermobility.
• Neurological symptoms: These can include developmental delay, seizures, and intellectual disability.

Genetics

The syndrome is believed to be inherited in an autosomal recessive pattern, meaning that both copies of the gene in each cell have mutations. The specific gene or genes involved in Walbaum–Titran–Durieux–Crepin syndrome have not yet been identified, and research is ongoing to better understand the genetic basis of the disorder.

Diagnosis

Diagnosis of Walbaum–Titran–Durieux–Crepin syndrome is based on clinical evaluation, family history, and the presence of characteristic symptoms. Genetic testing may be used to rule out other conditions with similar presentations.

Management

There is currently no cure for Walbaum–Titran–Durieux–Crepin syndrome. Management focuses on alleviating symptoms and improving quality of life. This may involve:

• Ophthalmologic care: Regular eye examinations and interventions such as surgery for cataracts or glaucoma.
• Orthopedic management: Physical therapy and orthopedic interventions to address skeletal abnormalities.
• Neurological support: Medications to control seizures and therapies to support developmental progress.

Prognosis

The prognosis for individuals with Walbaum–Titran–Durieux–Crepin syndrome varies depending on the severity of symptoms and the effectiveness of management strategies. Early intervention and supportive care can improve outcomes for affected individuals.

Also see

• Genetic disorders
• Rare diseases
• Syndromes
• Ocular abnormalities
• Skeletal dysplasia
• Neurological disorders

NIH genetic and rare disease info

• NIH info on Walbaum–Titran–Durieux–Crepin syndrome

Walbaum–Titran–Durieux–Crepin syndrome is a rare disease.